(Q39033554)

8 September 2017

Corticosteroid effects on sputum culture in pulmonary tuberculosis: a meta-regression analysis (English)

1 reference

8 September 2017

0 references

0 references

1 reference

pulmonary tuberculosis

1 reference

Robert S Wallis

1

1 reference

8 September 2017

1 March 2014

1 reference

Open Forum Infectious Diseases

8 September 2017

1 reference

8 September 2017

1

1 reference

8 September 2017

1

1 reference

8 September 2017

ofu020

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

8 September 2017

start time

28 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Appropriate DevR (DosR)-mediated signaling determines transcriptional response, hypoxic viability and virulence of Mycobacterium tuberculosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Letting sleeping dos lie: does dormancy play a role in tuberculosis?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Reconsidering adjuvant immunotherapy for tuberculosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Methylprednisolone pharmacokinetics after intravenous and oral administration

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Corticosteroids in primary tuberculosis with bronchial obstruction

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

CORTICOSTEROIDS IN PULMONARY TUBERCULOSIS. I. OVER-ALL RESULTS IN MADISON-MINNEAPOLIS VETERANS ADMINISTRATION HOSPITALS STEROID STUDY

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

The dormancy regulator DosR controls ribosome stability in hypoxic mycobacteria.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Adalimumab treatment of life-threatening tuberculosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324181

Biomarkers for tuberculosis disease activity, cure, and relapse

21 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FOFID%2FOFU020

Altered prednisolone pharmacokinetics in patients treated with rifampicin

21 January 2018

1 reference

12 December 2020

Corticotropin in the treatment of tuberculosis. A controlled study

1 reference

12 December 2020

TRIAL OF CORTICOTROPHIN AND PREDNISONE WITH CHEMOTHERAPY IN PULMONARY TUBERCULOSIS: A TWO-YEAR RADIOGRAPHIC FOLLOW-UP

1 reference

12 December 2020

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

1 reference

12 December 2020

Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial

1 reference

12 December 2020

Triamcinolone in primary pulmonary tuberculosis. A controlled trial

1 reference

12 December 2020

Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India

1 reference

12 December 2020

Corticosteroid treatment in fresh pulmonary tuberculosis. A preliminary report of a controlled trial

1 reference

12 December 2020

Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin

1 reference

12 December 2020

PREDNISOLONE IN THE TREATMENT OF PULMONARY TUBERCULOSIS; A UNITED STATES PUBLIC HEALTH SERVICE TUBERCULOSIS THERAPY TRIAL

1 reference

12 December 2020

Prednisolone in treatment of pulmonary tuberculosis: a controlled trial. Final report to the Research Committee of the Tuberculosis Society of Scotland

1 reference

12 December 2020

Tuberculosis, corticosteroid therapy, and pulmonary function

1 reference

12 December 2020

A randomized study of the effects of corticosteroid therapy on healing of pulmonary tuberculosis as judged by clinical, roentgenographic, and physiologic measurements

1 reference

12 December 2020

Adrenocorticosteroids in the treatment of tuberculosis

1 reference

12 December 2020

The role of adrenocorticortirophic and adrenocortico-steroid hormones in the treatment of tuberculosis

1 reference

12 December 2020

Adverse effect of rifampicin administration on steroid-dependent asthma

1 reference

12 December 2020

Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blind study. II. Further term observation

1 reference

12 December 2020

Identifiers

DOI

10.1093/OFID/OFU020

1 reference

8 September 2017

1 reference

PMC publication ID

4324181

8 September 2017

PubMed publication ID

25734093

1 reference

PMC publication ID

4324181